Patents by Inventor Angeliki Asimaki

Angeliki Asimaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Buccal cell diagnosis of arrhythmogenic cardiomyopathy (ACM)
    Patent number: 10317417
    Abstract: Described herein are, inter alia, methods for diagnosing and treating arrhythmogenic cardiomyopathy (ACM) by detecting cardiac intercalated disk proteins, e.g., desmosomal proteins, mechanical and gap junction proteins, in buccal cells. Exemplary desmosomal and gap junction proteins that can be evaluated in the methods described herein include plakoglobin, plakophilin 1, desmoplakin, and Cx43. The methods can also include selecting and/or administering a treatment for ACM to the subject.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: June 11, 2019
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Jeffrey E. Saffitz, Angeliki Asimaki
  • BUCCAL CELL DIAGNOSIS OF ARRHYTHMOGENIC CARDIOMYOPATHY (ACM)
    Publication number: 20180259539
    Abstract: Described herein are, inter alia, methods for diagnosing and treating arrhythmogenic cardiomyopathy (ACM) by detecting cardiac intercalated disk proteins, e.g., desmosomal proteins, mechanical and gap junction proteins, in buccal cells. Exemplary desmosomal and gap junction proteins that can be evaluated in the methods described herein include plakoglobin, plakophilin 1, desmoplakin, and Cx43. The methods can also include selecting and/or administering a treatment for ACM to the subject.
    Type: Application
    Filed: May 14, 2018
    Publication date: September 13, 2018
    Inventors: Jeffrey E. Saffitz, Angeliki Asimaki
  • Buccal cell diagnosis of arrhythmogenic cardiomyopathy (ACM)
    Patent number: 9995756
    Abstract: Described herein are, inter alia, methods for diagnosing and treating arrhythmogenic cardiomyopathy (ACM) by detecting cardiac intercalated disk proteins, e.g., desmosomal proteins, mechanical and gap junction proteins, in buccal cells. Exemplary desmosomal and gap junction proteins that can be evaluated in the methods described herein include plakoglobin, plakophilin 1, desmoplakin, and Cx43. The methods can also include selecting and/or administering a treatment for ACM to the subject.
    Type: Grant
    Filed: September 27, 2016
    Date of Patent: June 12, 2018
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Jeffrey E. Saffitz, Angeliki Asimaki
  • Buccal Cell Diagnosis of Arrhythmogenic Cardiomyopathy (ACM)
    Publication number: 20170097363
    Abstract: Described herein are, inter alia, methods for diagnosing and treating arrhythmogenic cardiomyopathy (ACM) by detecting cardiac intercalated disk proteins, e.g., desmosomal proteins, mechanical and gap junction proteins, in buccal cells. Exemplary desmosomal and gap junction proteins that can be evaluated in the methods described herein include plakoglobin, plakophilin 1, desmoplakin, and Cx43. The methods can also include selecting and/or administering a treatment for ACM to the subject.
    Type: Application
    Filed: September 27, 2016
    Publication date: April 6, 2017
    Inventors: Jeffrey E. Saffitz, Angeliki Asimaki